Srikripa Devarakonda
Stock Analyst at Truist Financial
(4.90)
# 271
Out of 5,060 analysts
525
Total ratings
56.8%
Success rate
24.7%
Average return
Main Sectors:
Stocks Rated by Srikripa Devarakonda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Reiterated: Hold | $115 | $113.07 | +1.71% | 38 | Oct 14, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Buy | $70 | $59.75 | +17.15% | 23 | Oct 13, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $77 | $39.90 | +92.98% | 34 | Oct 13, 2026 | |
| IVA Inventiva | Reiterated: Buy | n/a | $2.94 | - | 7 | Oct 2, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | n/a | $1,257.03 | - | 39 | Oct 1, 2026 | |
| AXSM Axsome Therapeutics | Initiated Coverage: Buy | $285 | $157.14 | +81.37% | 1 | Sep 23, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | n/a | $37.19 | - | 35 | Sep 23, 2026 | |
| NAMS NewAmsterdam Pharma Company | Reiterated: Buy | $57 | $19.83 | +187.44% | 6 | Sep 22, 2026 | |
| ABCL AbCellera Biologics | Reiterated: Buy | $30 | $11.80 | +154.24% | 14 | Sep 2, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $112 | $61.95 | +80.79% | 40 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $128.75 | - | 25 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $164 | $110.16 | +48.87% | 1 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.59 | - | 9 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $59 | $36.35 | +62.31% | 7 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $10 → $8.68 | $6.97 | +24.53% | 16 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 | $49.63 | +77.31% | 11 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $709 | $449.74 | +57.65% | 15 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.20 | - | 4 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.74 | - | 1 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $17 | $8.25 | +106.06% | 10 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $136 | $104.78 | +29.80% | 23 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.34 | - | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.66 | - | 21 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.4071 | - | 6 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $432.49 | - | 15 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $139 → $214 | $96.27 | +122.29% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $24.42 | -5.81% | 15 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $812 | $790.74 | +2.69% | 14 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 | $92.36 | n/a | 1 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.99 | n/a | 8 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $142 | $232.65 | n/a | 12 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8689 | n/a | 7 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $285.42 | n/a | 7 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $145.95 | n/a | 8 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $29.58 | n/a | 10 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 15 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9901 | n/a | 3 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $68.80 | n/a | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 | $8.65 | n/a | 13 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $38 | $0.000001 | n/a | 7 | Mar 20, 2023 |
Incyte
Oct 14, 2026
Reiterated: Hold
Price Target: $115
Current: $113.07
Upside: +1.71%
Bristol-Myers Squibb Company
Oct 13, 2026
Reiterated: Buy
Price Target: $70
Current: $59.75
Upside: +17.15%
Scholar Rock Holding
Oct 13, 2026
Reiterated: Buy
Price Target: $77
Current: $39.90
Upside: +92.98%
Inventiva
Oct 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.94
Upside: -
Eli Lilly and Company
Oct 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $1,257.03
Upside: -
Axsome Therapeutics
Sep 23, 2026
Initiated Coverage: Buy
Price Target: $285
Current: $157.14
Upside: +81.37%
Edgewise Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $37.19
Upside: -
NewAmsterdam Pharma Company
Sep 22, 2026
Reiterated: Buy
Price Target: $57
Current: $19.83
Upside: +187.44%
AbCellera Biologics
Sep 2, 2026
Reiterated: Buy
Price Target: $30
Current: $11.80
Upside: +154.24%
Cytokinetics
Sep 1, 2026
Reiterated: Buy
Price Target: $112
Current: $61.95
Upside: +80.79%
Sep 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $128.75
Upside: -
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $164
Current: $110.16
Upside: +48.87%
Aug 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.59
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: $43 → $59
Current: $36.35
Upside: +62.31%
Aug 10, 2026
Rated: Hold
Price Target: $10 → $8.68
Current: $6.97
Upside: +24.53%
Aug 10, 2026
Reiterated: Buy
Price Target: $88
Current: $49.63
Upside: +77.31%
Jul 31, 2026
Reiterated: Buy
Price Target: $709
Current: $449.74
Upside: +57.65%
Jul 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.20
Upside: -
Jul 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.74
Upside: -
Jul 2, 2026
Reiterated: Buy
Price Target: $11 → $17
Current: $8.25
Upside: +106.06%
Jun 29, 2026
Rated: Buy
Price Target: $136
Current: $104.78
Upside: +29.80%
Jun 8, 2026
Reiterated: Hold
Price Target: n/a
Current: $12.34
Upside: -
May 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.66
Upside: -
Mar 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.4071
Upside: -
Nov 5, 2025
Reiterated: Hold
Price Target: n/a
Current: $432.49
Upside: -
Nov 3, 2025
Reiterated: Buy
Price Target: $139 → $214
Current: $96.27
Upside: +122.29%
Oct 30, 2025
Reiterated: Buy
Price Target: $23
Current: $24.42
Upside: -5.81%
Oct 29, 2025
Reiterated: Buy
Price Target: $812
Current: $790.74
Upside: +2.69%
Oct 10, 2025
Reiterated: Buy
Price Target: $84
Current: $92.36
Upside: n/a
Aug 4, 2025
Rated: Hold
Price Target: n/a
Current: $0.99
Upside: n/a
Jul 21, 2025
Downgraded: Hold
Price Target: $142
Current: $232.65
Upside: n/a
Jul 9, 2025
Rated: Hold
Price Target: n/a
Current: $0.8689
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $285.42
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $145.95
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $29.58
Upside: n/a
Jan 28, 2025
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Dec 23, 2024
Rated: Hold
Price Target: n/a
Current: $0.9901
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: n/a
Current: $68.80
Upside: n/a
Oct 18, 2024
Rated: Buy
Price Target: $15
Current: $8.65
Upside: n/a
Mar 20, 2023
Downgraded: Hold
Price Target: $40 → $38
Current: $0.000001
Upside: n/a